£1.10m
+23%vs Mar 2024Active12028847Private limited companyNewcastle Upon Tyne
DEVELRX LIMITED
Significant control: Sharon Lesley Smith (25–50%), David John Heal (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Develrx Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DEVELRX LIMITED is an active private limited company (company number 12028847) incorporated on 3 June 2019, registered in Newcastle Upon Tyne. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £1.10m, with 4 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 23% on the prior period (£889k).
Peer position · net assets
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Dr Sharon Lesley Smith
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr David John Heal
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 3 June 20197 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 17 June 2027in 236 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
4
+33%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £1.10m | — | — | — | — | — | 4 |
| 31 March 2024 | £889k | — | — | — | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,097,858 at 31 March 2025
- Net assets up 10% or more on the prior period+23.4% vs prior period
- Incorporated five or more years agoIncorporated 3 June 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 236 days
- Next accounts duein 68 days
- Accounts period endNet assets £1.10m · micro accounts
- Accounts period endNet assets £889k · micro accounts
- Incorporated
08
Similar companies in Newcastle
- TREAT-NMD ALLIANCE LTDNewcastle Upon Tyne · inc. Jul 2019
- TREAT-NMD SERVICES LTDNewcastle Upon Tyne · inc. Jul 2019
- PEPMOTEC LIMITEDDurham · inc. Feb 2019
- NANOVERY LIMITEDNewcastle Upon Tyne · inc. Nov 2018
- PRECISION IMMUNOTHERAPEUTICS LIMITEDNewcastle Upon Tyne · inc. Nov 2018
- SUNDARA PHARMACEUTICALS LTDNewcastle Upon Tyne · inc. Oct 2018
All companies incorporated on 3 June 2019 · in Jun 2019.
09
Reminders for DEVELRX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.